Macrophage Activation in Lupus Nephritis: An Unknown Cause of Severe Hypercalcemia.

A Hispanic male in his 20s presented to the hospital with altered mental status and severe hypercalcemia. During his hospitalization, he developed clinical deterioration requiring intubation and ICU transfer. Initial work-up revealed low PTH and PTHrP levels, along with elevated vitamin D 25-OH and 1,25-OH levels. He developed progressive acute kidney injury, and a kidney biopsy later confirmed macrophage activation syndrome (MAS) in a background of type III lupus nephritis. His hypercalcemia resolved following pulse methylprednisolone therapy. Once clinically improved, the patient reported recent use of vitamin D supplementation. After excluding other causes of non-PTH-dependent hypercalcemia with elevated 1,25-OH vitamin D, MAS was determined to be the driver of increased 1-alpha hydroxylase activity, exacerbated by exogenous vitamin D. This is the first reported case of severe hypercalcemia due to MAS from lupus nephritis, compounded by vitamin D supplementation.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-11-03
Primary Topic
Vitamin D Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Macrophage Activation in Lupus Nephritis: An Unknown Cause of Severe Hypercalcemia.

Esra Sarı, CAROLINA SALDANHA NEVES HORTA LIMA, Ricaurte Crespo Trevino, Jeffrey Vercollone
PubMed
Vitamin D Research Studies
article

Macrophage Activation in Lupus Nephritis: An Unknown Cause of Severe Hypercalcemia.

Esra Sarı, CAROLINA SALDANHA NEVES HORTA LIMA, Ricaurte Crespo Trevino, Jeffrey Vercollone
article en

Abstract

A Hispanic male in his 20s presented to the hospital with altered mental status and severe hypercalcemia. During his hospitalization, he developed clinical deterioration requiring intubation and ICU transfer. Initial work-up revealed low PTH and PTHrP levels, along with elevated vitamin D 25-OH and 1,25-OH levels. He developed progressive acute kidney injury, and a kidney biopsy later confirmed macrophage activation syndrome (MAS) in a background of type III lupus nephritis. His hypercalcemia resolved following pulse methylprednisolone therapy. Once clinically improved, the patient reported recent use of vitamin D supplementation. After excluding other causes of non-PTH-dependent hypercalcemia with elevated 1,25-OH vitamin D, MAS was determined to be the driver of increased 1-alpha hydroxylase activity, exacerbated by exogenous vitamin D. This is the first reported case of severe hypercalcemia due to MAS from lupus nephritis, compounded by vitamin D supplementation.

PubMedVol. 108(11)
Tufts Medical Center (US), Salem Hospital (US), Southern District Health Board (NZ)
Openalex Percentile: Top 56%
Vitamin D Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.